
Monographie Open Access Vollzugriff
Patents and Public Health
Legalising the Policy Thoughts in the Doha TRIPS Declaration of 14 November 2001- Autor:innen:
- Reihe:
- Munich Intellectual Property Law Center - MIPLC Studies, Band 3
- Verlag:
- 2009
Zusammenfassung
Der Autor untersucht die Bedeutung des TRIPS-Abkommens für die öffentliche Gesundheit. Im Mittelpunkt steht die Frage, inwieweit der Patentschutz im Pharmabereich negative Auswirkungen auf die Versorgung der Bevölkerung in Entwicklungsländern mit lebenswichtigen Medikamenten hat.
Publikation durchsuchen
Bibliographische Angaben
- Copyrightjahr
- 2009
- ISBN-Print
- 978-3-8329-4078-2
- ISBN-Online
- 978-3-8452-1265-4
- Verlag
- Nomos, Baden-Baden
- Reihe
- Munich Intellectual Property Law Center - MIPLC Studies
- Band
- 3
- Sprache
- Englisch
- Seiten
- 292
- Produkttyp
- Monographie
Inhaltsverzeichnis
KapitelSeiten
- Titelei/InhaltsverzeichnisSeiten 2 - 16 Download Kapitel (PDF)
- IntroductionSeiten 17 - 18 Download Kapitel (PDF)
- Patents and societySeiten 19 - 25 Download Kapitel (PDF)
- The legalising policy thoughts in the Public Health DeclarationSeiten 26 - 28 Download Kapitel (PDF)
- IntroductionSeiten 29 - 30 Download Kapitel (PDF)
- The GATT system and the Uruguay RoundSeiten 30 - 34 Download Kapitel (PDF)
- The implementation of the TRIPS AgreementSeiten 34 - 41 Download Kapitel (PDF)
- Nature and scope of the TRIPS AgreementSeiten 42 - 47 Download Kapitel (PDF)
- An analysis of the preambleSeiten 47 - 51 Download Kapitel (PDF)
- An analysis of Article 7 TRIPSSeiten 51 - 53 Download Kapitel (PDF)
- An analysis of Article 8.1 TRIPSSeiten 53 - 56 Download Kapitel (PDF)
- An analysis of Article 8.2 TRIPS AgreementSeiten 56 - 58 Download Kapitel (PDF)
- The influence of the international customary rule of interpretation on the object and purpose provisionsSeiten 58 - 60 Download Kapitel (PDF)
- The flexibilities found in the object and purposes provisions
- The role of the object and purpose provisions in flexibilities found in other TRIPS provision
- The relevance given to the role of flexibility in the object and purpose provisions by the Member States
- The role of health in the object and purpose of the TRIPS AgreementSeiten 65 - 68 Download Kapitel (PDF)
- Other influences on the object and purpose of the TRIPS AgreementSeiten 68 - 69 Download Kapitel (PDF)
- Article 27.1 of the TRIPS Agreement
- Commercial exploitation
- Necessity
- Discrimination and differentiation
- Implementation restrictions relating to the Article 27.2 exclusion
- Conclusion
- Rights conferred to the patent holderSeiten 85 - 86 Download Kapitel (PDF)
- Revocation
- Limited exceptions
- The compulsory license system
- Grounds for compulsory licenses
- Discrimination
- Causality approach
- The relationship between Article 31 of the TRIPS Agreement and Article 5A(4) of the Paris Convention
- Commercial use of compulsory licenses
- Article 31 (a)
- Article 31 (b), first sentence
- Extreme urgencies and national emergencies
- Public non-commercial use
- Scope
- Duration
- Article 31 (d)
- Article 31 (e)
- Article 31 (f)
- Article 31 (g)
- Article 31 (h)
- Article 31 (i and j)
- Article 31 (k)
- Conclusion
- DisclosureSeiten 145 - 149 Download Kapitel (PDF)
- ExhaustionSeiten 149 - 154 Download Kapitel (PDF)
- ConclusionSeiten 154 - 155 Download Kapitel (PDF)
- Clarification of the relationship between the TRIPS Agreement and public healthSeiten 156 - 159 Download Kapitel (PDF)
- Countries without domestic productions facilitiesSeiten 159 - 160 Download Kapitel (PDF)
- The postponed implementation of certain TRIPS-obligationsSeiten 160 - 161 Download Kapitel (PDF)
- The legal status of the Public Health DeclarationSeiten 161 - 163 Download Kapitel (PDF)
- The customary rules of interpretation
- The Public Health Declaration and Articles 7 and 8 of the TRIPS Agreement
- The Public Health Declaration and the right to health
- Conclusion
- Exhaustion
- The flexibilities in paragraph 5 of the Public Health Declaration
- Paragraph 5(b) of the Public Health Declaration
- Paragraph 5(c) of the Public Health Declaration
- Subsequent developments
- Conclusion
- Paragraph 7 of the Public Health Declaration
- The TRIPS Council decision extending the transition period
- The General Council waiver of Article 70.9
- Member States without domestic pharmaceutical production facilitiesSeiten 185 - 185 Download Kapitel (PDF)
- The scope of paragraph 6Seiten 186 - 187 Download Kapitel (PDF)
- Manufacturing capacitySeiten 187 - 188 Download Kapitel (PDF)
- Insufficient or no capacitiesSeiten 188 - 188 Download Kapitel (PDF)
- Pharmaceutical sectorSeiten 188 - 189 Download Kapitel (PDF)
- Effective use of the compulsory license systemSeiten 189 - 189 Download Kapitel (PDF)
- Potential paragraph 6 solutionsSeiten 189 - 190 Download Kapitel (PDF)
- The waivers in the Decision
- The Decision’s moratorium
- The Chairman’s Statement
- The scope of the DecisionSeiten 197 - 198 Download Kapitel (PDF)
- The pharmaceutical product
- The exporting Member State
- The importing Member State
- Conclusion
- Safeguards inherent to the system
- General safeguards
- Transfer of technology
- Procedure for the adoption of a final solutionSeiten 217 - 218 Download Kapitel (PDF)
- Article 31 bis of the TRIPS AgreementSeiten 218 - 222 Download Kapitel (PDF)
- NorwaySeiten 223 - 228 Download Kapitel (PDF)
- CanadaSeiten 228 - 234 Download Kapitel (PDF)
- The NetherlandsSeiten 234 - 236 Download Kapitel (PDF)
- IndiaSeiten 236 - 238 Download Kapitel (PDF)
- ECSeiten 238 - 242 Download Kapitel (PDF)
- International and multilateral policies and measuresSeiten 242 - 242 Download Kapitel (PDF)
- Bilateral policies and measuresSeiten 242 - 245 Download Kapitel (PDF)
- National policies and measuresSeiten 245 - 247 Download Kapitel (PDF)
- ConclusionSeiten 247 - 247 Download Kapitel (PDF)
- Definitive consequences of the Public Health DeclarationSeiten 248 - 250 Download Kapitel (PDF)
- BibliographySeiten 251 - 261 Download Kapitel (PDF)
- Cited treaties, legislation and similar legal documentsSeiten 262 - 267 Download Kapitel (PDF)
- Cited casesSeiten 268 - 271 Download Kapitel (PDF)
- Public Health DeclarationSeiten 272 - 274 Download Kapitel (PDF)
- 30 August 2003 DecisionSeiten 275 - 281 Download Kapitel (PDF)
- The Article 31 bis AmendmentSeiten 282 - 290 Download Kapitel (PDF)
- Examples of royalty rates in compulsory licensing & related casesSeiten 291 - 292 Download Kapitel (PDF)




